PPT-1 Reducing the Incidence of VTE Among Gynecologic Oncology Patients

Author : celsa-spraggs | Published Date : 2018-10-13

Charles Levenback MD Professor and Deputy Chair for Patient Care Gynecologic Oncology Center Medical Director Lisa Kidin RN MSN MHA Sr Business Systems Analyst

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "1 Reducing the Incidence of VTE Among Gy..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

1 Reducing the Incidence of VTE Among Gynecologic Oncology Patients: Transcript


Charles Levenback MD Professor and Deputy Chair for Patient Care Gynecologic Oncology Center Medical Director Lisa Kidin RN MSN MHA Sr Business Systems Analyst Deep vein thrombosis DVT. Phil clin Psych students Elective international student teaching Public Cancer Awareness Programmes Dr Suraj Manjunath Associate Professor Head of Department Dr Shiva Kumar K Assistant Professor Dr Rakesh S R amesh Assistant Professor Dr Tanveer Huss This means that 1 in every 733 babies is born with this condition Although parents of any age may have a child with Down syndrome 80 are born to women under the age of 35 NICHCY Disability Fact Sheet 4 June 2010 Definition Definition Definition Defi Updates and Clarification to the Process. This NetLearning is meant to clarify common confusion regarding the VTE Prophylaxis Process. . If you did not attend a Meaningful Use Class or take the original NetLearning, “Meaningful Use Mandatory NetLearning”, please view both to ensure that you understand the process completely!. A Novel Laser Therapy. MLTU-PPPT-A-R2. Become Yourself Again. Gynecologic . Health. A Novel Laser Therapy. MLTU-PPPT-A-R2. “It” refers to changes in gynecologic . health . and it happens to a majority of women.. Magee-. Womens. Hospital of UPMC. Clinical and Research Updates in Gynecologic Oncology. Gynecologic Cancer in the United States. American Cancer Society, 2017. New Cases. Cancer Deaths. Ovary. 22,440. A Centers for Disease Control and Prevention Campaign. What We Will Discuss. Part I. What You Need to Know About Gynecologic Cancers. Part II: Recognizing the Warning Signs. Part III: Prevention, Screening, and Treatment. Protocol GOG-0258. Louise E. Francis, B.S., CMD. Gynecologic Oncology Group. . (GOG). The only National Cancer Institute funded cooperative group. . in the US currently conducting trials 0n gynecologic cancers. The NIMC VTE Pilot. How to use the NIMC VTE prophylaxis section. Frequently asked questions. Extent of issue. In 2008:. VTE cases 14,716. Deaths 5,285. Working age 43%. Total inpatient costs $81.2m. Special Situations. Atrial Thrombus Treatment Options. Algorithm. A Few Notes on Special Situations. Bridging. Reversal. In Your Leisure Time. Review: . Kearon et al. Antithrombotic Therapy for VTE Disease : CHEST Guideline and Expert Panel Report. . Dr Henan Dh Skheel. Department Of . Obs&Gyn. 2020. Venous . thromboembolism.  (. VTE) is a collective term that describes deep vein thrombosis (DVT) and pulmonary embolism (PE).. Venous thromboembolism is a leading cause of . the development research projects and educational the past at an the management malignant neoplasm requires a multi- disciplinary approach, which includes Gynecologic Oncology years. During subspecial Unit. Case information: Ovarian cancer. Objectives. This chapter . aims to develop in students . able to. Use . frequently used . vocabulary . and . technical terms . about . gynecology. Communicate with patients related to hospitalized situation . • CS slate. F5 (5). • Call . D1(3). F2(5). F3(10). F4(5) . F6(3). C3(10). •Get . F3 . for any UCC visits . •Get . F2. for visits for ↓FM & interpreting NST . SPH . . • CS slate. 2,3. Emily V. Dressler, PhD. 4. ; David I. Shalowitz, MD, MSHP. 1,2.  . 1 . Section on Gynecologic Oncology, Department of Obstetrics and . Gynecology, . 2 . Department of Implementation . Science, .

Download Document

Here is the link to download the presentation.
"1 Reducing the Incidence of VTE Among Gynecologic Oncology Patients"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents